Autumn J. McRee

Pembrolizumab for patients with PD-L1-positive advanced gastric cancer (KEYNOTE-012): a multicentre, open-label, phase 1b trial

Kei Muro, Hyun Cheol Chung, Veena Shankaran et al. · The Lancet Oncology · 2016 · 1.1K citations · Full text

Medicine, Oncology, Pharmacotherapy +12

Combined BRAF, EGFR, and MEK Inhibition in Patients with <i>BRAF</i> V600E-Mutant Colorectal Cancer

Ryan B. Corcoran, Thierry André, Chloé E. Atreya et al. · Cancer Discovery · 2018 · 583 citations · Full text

Medicine, Oncology, Pharmacology +17

Combination Therapies with CDK4/6 Inhibitors to Treat <i>KRAS-</i> Mutant Pancreatic Cancer

Craig M. Goodwin, Andrew M. Waters, Jennifer E. Klomp et al. · Cancer Research · 2022 · 160 citations · Full text

Medicine, Oncology, Pharmacology +17

A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metastatic pancreatic cancer

Bert H. O’Neil, Aaron J. Scott, W.W. Ma et al. · Annals of Oncology · 2015 · 141 citations · Full text

Medicine, Oncology, Pharmacology +13

B cell–Derived IL35 Drives STAT3-Dependent CD8+ T-cell Exclusion in Pancreatic Cancer

Bhalchandra Mirlekar, Daniel Michaud, Samuel Lee et al. · Cancer Immunology Research · 2020 · 112 citations · Full text

Medicine, Immunology, Oncology +10